These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1310098)

  • 1. Autoantibodies to leucocyte antigens in hydralazine-associated nephritis.
    Almroth G; Eneström S; Hed J; Samuelsson I; Sjöström P
    J Intern Med; 1992 Jan; 231(1):37-42. PubMed ID: 1310098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis.
    Torffvit O; Thysell H; Nässberger L
    Hum Exp Toxicol; 1994 Aug; 13(8):563-7. PubMed ID: 7946512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimyeloperoxidase antibodies in patients with extracapillary glomerulonephritis.
    Nässberger L; Sjöholm AG; Thysell H
    Nephron; 1990; 56(2):152-6. PubMed ID: 2173810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.
    Nässberger L; Sjöholm AG; Jonsson H; Sturfelt G; Akesson A
    Clin Exp Immunol; 1990 Sep; 81(3):380-3. PubMed ID: 2168822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis.
    Cambridge G; Wallace H; Bernstein RM; Leaker B
    Br J Rheumatol; 1994 Feb; 33(2):109-14. PubMed ID: 8162472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine-associated glomerulonephritis.
    Björck S; Svalander C; Westberg G
    Acta Med Scand; 1985; 218(3):261-9. PubMed ID: 3907285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA; Gallicchio M; Georgiou T; Davies DJ
    Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment.
    Nässberger L; Johansson AC; Björck S; Sjöholm AG
    J Intern Med; 1991 Mar; 229(3):261-5. PubMed ID: 1848881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of autoantibodies against neutrophil granulocyte components in juvenile chronic arthritis.
    Nässberger L; Truedsson L; Svantesson H
    Clin Exp Rheumatol; 1991; 9(1):79-83. PubMed ID: 1647282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
    Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
    J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.
    Short AK; Lockwood CM
    QJM; 1995 Nov; 88(11):775-83. PubMed ID: 8542262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
    Kumar B; Strouse J; Swee M; Lenert P; Suneja M
    Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.
    Ueda H; Ishimura E; Yunoki T; Tsuchida T; Matsumoto N; Jono S; Imanishi Y; Inaba M; Nishizawa Y
    Clin Exp Nephrol; 2005 Dec; 9(4):332-334. PubMed ID: 16362162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute tubulo-interstitial nephritis with positive anti-neutrophil cytoplasmic antibodies.
    Hassani K; Hamzi AM; Hassani M; Benyahia M
    Arab J Nephrol Transplant; 2013 Sep; 6(3):177-9. PubMed ID: 24053745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydralazine-induced MPO-ANCA Renal-Limited Vasculitis Masquerading as Lupus Nephritis.
    Baloch NU; Ibeabuchi AN
    J Coll Physicians Surg Pak; 2018 Nov; 28(11):896-897. PubMed ID: 30369391
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.
    Falk RJ; Jennette JC
    N Engl J Med; 1988 Jun; 318(25):1651-7. PubMed ID: 2453802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in systemic vasculitis.
    Savige JA; Gallicchio M; Chang L; Parkin JD
    Aust N Z J Med; 1991 Aug; 21(4):433-7. PubMed ID: 1659359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis.
    Son D; Kanda H; Yamaguchi A; Kawabata K; Kawakami T; Kubo K; Higashihara M; Shimizu J; Uozaki H; Kuramochi S; Misaki Y; Takeuchi F; Yamamoto K
    J Nephrol; 2009; 22(3):417-20. PubMed ID: 19557721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dense intramembranous deposit disease: new pathologic features.
    Sibley RK; Kim Y
    Kidney Int; 1984 Apr; 25(4):660-70. PubMed ID: 6482170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.